An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in ...

Just like Taylor Swift during her Eras Tour, it seems like weight loss supplements are everywhere right now—and that includes insulin resistance supps. Supplement companies market insulin resistance ...

NIH-funded study illuminates the structural features of memory formation at cellular and subcellular levels: Bethesda, Maryland Saturday, March 22, 2025, 14:00 Hrs [IST] In a stud ...

Explore how UCT’s boycott of Israeli universities and a potential NIH funding cut threaten its financial stability in 2025, ...

NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

Proposition 103 may have been well-intentioned, but good intentions often lead to unintended consequences. Insurance ...

Massachusetts General Hospital received $655 million in funding from the National Institutes of Health in fiscal 2024 — a slight decrease from the $675 million it secured in 2023, yet it remained the ...

HHS Secretary RFK Jr., with help from DOGE, is planning a restructuring with sweeping cuts expected at multiple agencies.

Sam Srisatta, a 20-year-old Florida college student, spent a month living inside a government hospital here last fall, ...

The Associated Press AN experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in their 40s or 50s, according to new findings from ongoing ...

Proposed cuts to National Institutes of Health funding threaten a critical pipeline of innovation and discovery necessary to fuel advancements in patient care, according to researchers and provider ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.